Literature DB >> 3082676

Crystallographic investigation of the cooperative interaction between trimethoprim, reduced cofactor and dihydrofolate reductase.

J N Champness, D K Stammers, C R Beddell.   

Abstract

The structure of the complex between E. coli (RT500) form I dihydrofolate reductase, the antibacterial trimethoprim and NADPH has been determined by X-ray crystallography. The inhibitor and cofactor are in mutual contact. A flexible chain segment which includes Met 20 is in contact with the inhibitor in the presence of NADPH, but more distant in its absence. By contrast, the inhibitor conformation is little changed with NADPH present. We discuss these observations with regard to the mutually cooperative binding of these ligands to the protein, and to the associated enhancement of inhibitory selectivity shown by trimethoprim for bacterial as opposed to vertebrate enzyme.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082676     DOI: 10.1016/0014-5793(86)81224-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Drug design by machine learning: the use of inductive logic programming to model the structure-activity relationships of trimethoprim analogues binding to dihydrofolate reductase.

Authors:  R D King; S Muggleton; R A Lewis; M J Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  The discovery of indicator variables for QSAR using inductive logic programming.

Authors:  R D King; A Srinivasan
Journal:  J Comput Aided Mol Des       Date:  1997-11       Impact factor: 3.686

3.  A genetic algorithm for the automated generation of molecules within constraints.

Authors:  R C Glen; A W Payne
Journal:  J Comput Aided Mol Des       Date:  1995-04       Impact factor: 3.686

Review 4.  Distal Regions Regulate Dihydrofolate Reductase-Ligand Interactions.

Authors:  Melanie Goldstein; Nina M Goodey
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Tetrahydrofolate and tetrahydromethanopterin compared: functionally distinct carriers in C1 metabolism.

Authors:  B E Maden
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

6.  Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogens.

Authors:  Jolanta Krucinska; Michael N Lombardo; Heidi Erlandsen; Alexavier Estrada; Debjani Si; Kishore Viswanathan; Dennis L Wright
Journal:  Commun Biol       Date:  2022-05-13

7.  Quantitative structure-activity relationships by neural networks and inductive logic programming. I. The inhibition of dihydrofolate reductase by pyrimidines.

Authors:  J D Hirst; R D King; M J Sternberg
Journal:  J Comput Aided Mol Des       Date:  1994-08       Impact factor: 3.686

8.  Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania.

Authors:  F Zuccotto; A C Martin; R A Laskowski; J M Thornton; I H Gilbert
Journal:  J Comput Aided Mol Des       Date:  1998-05       Impact factor: 3.686

9.  Ultraviolet resonance Raman study of drug binding in dihydrofolate reductase, gyrase, and catechol O-methyltransferase.

Authors:  V W Couling; P Fischer; D Klenerman; W Huber
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

10.  Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus.

Authors:  Siyu Wang; Stephanie M Reeve; Graham T Holt; Adegoke A Ojewole; Marcel S Frenkel; Pablo Gainza; Santosh Keshipeddy; Vance G Fowler; Dennis L Wright; Bruce R Donald
Journal:  PLoS Comput Biol       Date:  2022-02-10       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.